LIGAND PHARMA (LGDN BE) stock market data APIs
€182.6407
1.98(1.1%)
as of March 18, 2026
Try our APIs with
free plan!
LIGAND PHARMA Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for LGDN.BE.
Prev. Close
182.6407
Open
184.6189
High
185.8397
Low
182.4351
52 wk Range
85.5-186
Market Cap
2 130 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get LIGAND PHARMA data using free add-ons & libraries
Get LIGAND PHARMA Fundamental Data
LIGAND PHARMA Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LIGAND PHARMA News
New
Oracle, Nike upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...
Ligand Pharmaceuticals (LGND) Is Up 7.8% After Swing to Profit and New ATM Offering Filed – Has The Bull Case Changed?
In late February 2026, Ligand Pharmaceuticals reported past fourth-quarter 2025 revenue of US$59.67 million and full-year 2025 revenue of US$268.09 million, moving from a prior-year net loss to net in...
Ligand Pharmaceuticals Inc (LGND) Q4 2025 Earnings Call Highlights: Surpassing Expectations and ...
This article first appeared on GuruFocus. Release Date: February 26, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Ligan...
Ligand: Q4 Earnings Snapshot
JUPITER, Fla. (AP) — JUPITER, Fla. (AP) — Ligand Pharmaceuticals Inc. (LGND) on Thursday reported fourth-quarter earnings of $44.8 million. On a per-share basis, the Jupiter, Florida-based compan...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
